House Subcommittee Recommends $137.7 Million Increase For NCI
In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute
NCI Names Brawly Director of Office of Special Populations
Owens Becomes President, NCCR
FDA approves Irinotecan, Days After ODAC Meeting
ODAC Recommends FDA Approval For Grain Tumor Implant
Letter: Headline Criticized On Letter About Consortium
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









